Design and synthesis of dipeptidyl glutaminyl fluoromethyl ketones as potent severe acute respiratory syndrome coronovirus (SARS-CoV) inhibitors.
Identifieur interne : 001362 ( Ncbi/Curation ); précédent : 001361; suivant : 001363Design and synthesis of dipeptidyl glutaminyl fluoromethyl ketones as potent severe acute respiratory syndrome coronovirus (SARS-CoV) inhibitors.
Auteurs : Han-Zhong Zhang [États-Unis] ; Hong Zhang ; William Kemnitzer ; Ben Tseng ; Jindrich Cinatl ; Martin Michaelis ; Hans Wilhelm Doerr ; Sui Xiong CaiSource :
- Journal of medicinal chemistry [ 0022-2623 ] ; 2006.
Descripteurs français
- KwdFr :
- MESH :
- pharmacologie : Antiviraux, Dipeptides.
- synthèse chimique : Antiviraux, Dipeptides.
- Animaux, Antiviraux, Cellules Caco-2, Cellules Vero, Conception de médicament, Dipeptides, Humains, Mort cellulaire, Réplication virale, Virus du SRAS.
English descriptors
- KwdEn :
- Animals, Antiviral Agents (chemical synthesis), Antiviral Agents (chemistry), Antiviral Agents (pharmacology), Caco-2 Cells, Cell Death (drug effects), Chlorocebus aethiops, Dipeptides (chemical synthesis), Dipeptides (chemistry), Dipeptides (pharmacology), Drug Design, Humans, SARS Virus (drug effects), Vero Cells, Virus Replication.
- MESH :
- chemical , chemical synthesis : Antiviral Agents, Dipeptides.
- chemical , chemistry : Antiviral Agents, Dipeptides.
- chemical , pharmacology : Antiviral Agents, Dipeptides.
- drug effects : Cell Death, SARS Virus.
- Animals, Caco-2 Cells, Chlorocebus aethiops, Drug Design, Humans, Vero Cells, Virus Replication.
Abstract
This paper describes the design and synthesis of dipeptidyl N,N-dimethyl glutaminyl fluoromethyl ketones (fmk) as severe acute respiratory syndrome coronovirus (SARS-CoV) inhibitors. The compounds were tested against SARS-CoV-induced cell death in Vero or CaCo2 cells as a measurement of the inhibiting effects of the compounds on the replication of the virus. Z-Leu-Gln(NMe(2))-fmk (6a) was found to be a potent inhibitor with low toxicity in cells, protecting cells with an EC(50) value of 2.5 microM and exhibiting a selectivity index of >40.
DOI: 10.1021/jm0507678
PubMed: 16451084
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :002358
- to stream PubMed, to step Curation: Pour aller vers cette notice dans l'étape Curation :002358
- to stream PubMed, to step Checkpoint: Pour aller vers cette notice dans l'étape Curation :002232
- to stream Ncbi, to step Merge: Pour aller vers cette notice dans l'étape Curation :001362
Links to Exploration step
pubmed:16451084Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Design and synthesis of dipeptidyl glutaminyl fluoromethyl ketones as potent severe acute respiratory syndrome coronovirus (SARS-CoV) inhibitors.</title>
<author><name sortKey="Zhang, Han Zhong" sort="Zhang, Han Zhong" uniqKey="Zhang H" first="Han-Zhong" last="Zhang">Han-Zhong Zhang</name>
<affiliation wicri:level="2"><nlm:affiliation>Maxim Pharmaceuticals, 6650 Nancy Ridge Drive, San Diego, CA 92121, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Maxim Pharmaceuticals, 6650 Nancy Ridge Drive, San Diego, CA 92121</wicri:regionArea>
<placeName><region type="state">Californie</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Zhang, Hong" sort="Zhang, Hong" uniqKey="Zhang H" first="Hong" last="Zhang">Hong Zhang</name>
</author>
<author><name sortKey="Kemnitzer, William" sort="Kemnitzer, William" uniqKey="Kemnitzer W" first="William" last="Kemnitzer">William Kemnitzer</name>
</author>
<author><name sortKey="Tseng, Ben" sort="Tseng, Ben" uniqKey="Tseng B" first="Ben" last="Tseng">Ben Tseng</name>
</author>
<author><name sortKey="Cinatl, Jindrich" sort="Cinatl, Jindrich" uniqKey="Cinatl J" first="Jindrich" last="Cinatl">Jindrich Cinatl</name>
</author>
<author><name sortKey="Michaelis, Martin" sort="Michaelis, Martin" uniqKey="Michaelis M" first="Martin" last="Michaelis">Martin Michaelis</name>
</author>
<author><name sortKey="Doerr, Hans Wilhelm" sort="Doerr, Hans Wilhelm" uniqKey="Doerr H" first="Hans Wilhelm" last="Doerr">Hans Wilhelm Doerr</name>
</author>
<author><name sortKey="Cai, Sui Xiong" sort="Cai, Sui Xiong" uniqKey="Cai S" first="Sui Xiong" last="Cai">Sui Xiong Cai</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2006">2006</date>
<idno type="RBID">pubmed:16451084</idno>
<idno type="pmid">16451084</idno>
<idno type="doi">10.1021/jm0507678</idno>
<idno type="wicri:Area/PubMed/Corpus">002358</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002358</idno>
<idno type="wicri:Area/PubMed/Curation">002358</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">002358</idno>
<idno type="wicri:Area/PubMed/Checkpoint">002232</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">002232</idno>
<idno type="wicri:Area/Ncbi/Merge">001362</idno>
<idno type="wicri:Area/Ncbi/Curation">001362</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Design and synthesis of dipeptidyl glutaminyl fluoromethyl ketones as potent severe acute respiratory syndrome coronovirus (SARS-CoV) inhibitors.</title>
<author><name sortKey="Zhang, Han Zhong" sort="Zhang, Han Zhong" uniqKey="Zhang H" first="Han-Zhong" last="Zhang">Han-Zhong Zhang</name>
<affiliation wicri:level="2"><nlm:affiliation>Maxim Pharmaceuticals, 6650 Nancy Ridge Drive, San Diego, CA 92121, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Maxim Pharmaceuticals, 6650 Nancy Ridge Drive, San Diego, CA 92121</wicri:regionArea>
<placeName><region type="state">Californie</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Zhang, Hong" sort="Zhang, Hong" uniqKey="Zhang H" first="Hong" last="Zhang">Hong Zhang</name>
</author>
<author><name sortKey="Kemnitzer, William" sort="Kemnitzer, William" uniqKey="Kemnitzer W" first="William" last="Kemnitzer">William Kemnitzer</name>
</author>
<author><name sortKey="Tseng, Ben" sort="Tseng, Ben" uniqKey="Tseng B" first="Ben" last="Tseng">Ben Tseng</name>
</author>
<author><name sortKey="Cinatl, Jindrich" sort="Cinatl, Jindrich" uniqKey="Cinatl J" first="Jindrich" last="Cinatl">Jindrich Cinatl</name>
</author>
<author><name sortKey="Michaelis, Martin" sort="Michaelis, Martin" uniqKey="Michaelis M" first="Martin" last="Michaelis">Martin Michaelis</name>
</author>
<author><name sortKey="Doerr, Hans Wilhelm" sort="Doerr, Hans Wilhelm" uniqKey="Doerr H" first="Hans Wilhelm" last="Doerr">Hans Wilhelm Doerr</name>
</author>
<author><name sortKey="Cai, Sui Xiong" sort="Cai, Sui Xiong" uniqKey="Cai S" first="Sui Xiong" last="Cai">Sui Xiong Cai</name>
</author>
</analytic>
<series><title level="j">Journal of medicinal chemistry</title>
<idno type="ISSN">0022-2623</idno>
<imprint><date when="2006" type="published">2006</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Animals</term>
<term>Antiviral Agents (chemical synthesis)</term>
<term>Antiviral Agents (chemistry)</term>
<term>Antiviral Agents (pharmacology)</term>
<term>Caco-2 Cells</term>
<term>Cell Death (drug effects)</term>
<term>Chlorocebus aethiops</term>
<term>Dipeptides (chemical synthesis)</term>
<term>Dipeptides (chemistry)</term>
<term>Dipeptides (pharmacology)</term>
<term>Drug Design</term>
<term>Humans</term>
<term>SARS Virus (drug effects)</term>
<term>Vero Cells</term>
<term>Virus Replication</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Animaux</term>
<term>Antiviraux ()</term>
<term>Antiviraux (pharmacologie)</term>
<term>Antiviraux (synthèse chimique)</term>
<term>Cellules Caco-2</term>
<term>Cellules Vero</term>
<term>Conception de médicament</term>
<term>Dipeptides ()</term>
<term>Dipeptides (pharmacologie)</term>
<term>Dipeptides (synthèse chimique)</term>
<term>Humains</term>
<term>Mort cellulaire ()</term>
<term>Réplication virale</term>
<term>Virus du SRAS ()</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="chemical synthesis" xml:lang="en"><term>Antiviral Agents</term>
<term>Dipeptides</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="chemistry" xml:lang="en"><term>Antiviral Agents</term>
<term>Dipeptides</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="pharmacology" xml:lang="en"><term>Antiviral Agents</term>
<term>Dipeptides</term>
</keywords>
<keywords scheme="MESH" qualifier="drug effects" xml:lang="en"><term>Cell Death</term>
<term>SARS Virus</term>
</keywords>
<keywords scheme="MESH" qualifier="pharmacologie" xml:lang="fr"><term>Antiviraux</term>
<term>Dipeptides</term>
</keywords>
<keywords scheme="MESH" qualifier="synthèse chimique" xml:lang="fr"><term>Antiviraux</term>
<term>Dipeptides</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Animals</term>
<term>Caco-2 Cells</term>
<term>Chlorocebus aethiops</term>
<term>Drug Design</term>
<term>Humans</term>
<term>Vero Cells</term>
<term>Virus Replication</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Animaux</term>
<term>Antiviraux</term>
<term>Cellules Caco-2</term>
<term>Cellules Vero</term>
<term>Conception de médicament</term>
<term>Dipeptides</term>
<term>Humains</term>
<term>Mort cellulaire</term>
<term>Réplication virale</term>
<term>Virus du SRAS</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">This paper describes the design and synthesis of dipeptidyl N,N-dimethyl glutaminyl fluoromethyl ketones (fmk) as severe acute respiratory syndrome coronovirus (SARS-CoV) inhibitors. The compounds were tested against SARS-CoV-induced cell death in Vero or CaCo2 cells as a measurement of the inhibiting effects of the compounds on the replication of the virus. Z-Leu-Gln(NMe(2))-fmk (6a) was found to be a potent inhibitor with low toxicity in cells, protecting cells with an EC(50) value of 2.5 microM and exhibiting a selectivity index of >40.</div>
</front>
</TEI>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/Ncbi/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001362 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd -nk 001362 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= SrasV1 |flux= Ncbi |étape= Curation |type= RBID |clé= pubmed:16451084 |texte= Design and synthesis of dipeptidyl glutaminyl fluoromethyl ketones as potent severe acute respiratory syndrome coronovirus (SARS-CoV) inhibitors. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/RBID.i -Sk "pubmed:16451084" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd \ | NlmPubMed2Wicri -a SrasV1
This area was generated with Dilib version V0.6.33. |